proline has been researched along with carbazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chengyin, W; Guan, J; Lv, H; Teng, Z; Zhang, Y | 1 |
| Ahuja, V; Delucca, G; Dodd, D; Everlof, G; Gavai, AV; Gill, P; Han, WC; Harikrishnan, L; Huang, C; Hunt, JT; Huynh, T; Kamau, M; Lee, FY; Li, J; Li, P; Marsilio, F; Mathur, A; Menard, K; Mussari, C; Norris, D; O'Malley, D; Poss, M; Quesnelle, C; Raghavan, N; Rampulla, R; Ranasinghe, A; Sheriff, S; Sun, D; Tokarski, JS; Tortolani, D; Traeger, SC; Tye, CK; Vaccaro, W; Vite, G; Wee, S; Wen, ML; Westhouse, R; Wu, DR; Yan, C; Yang, Z; Yip, H; Zhang, H; Zhang, Y; Zhao, Y | 1 |
2 other study(ies) available for proline and carbazole
| Article | Year |
|---|---|
Development of a Fluorescent Labeling Reagent for Determination of Proline and Hydroxyproline in Myeloma Patient Plasma by HPLC-FLD.
Topics: Blood Chemical Analysis; Carbazoles; Chromatography, High Pressure Liquid; Fluorescent Dyes; Humans; Hydroxyproline; Limit of Detection; Multiple Myeloma; Proline; Spectrometry, Fluorescence | 2016 |
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design.
Topics: Administration, Oral; Antineoplastic Agents; Carbazoles; Cell Cycle Proteins; Dose-Response Relationship, Drug; Drug Discovery; Humans; Molecular Structure; Phenylalanine; Proline; Structure-Activity Relationship; Transcription Factors; Tryptophan | 2021 |